Harmonemia: A universal strategy for flow cytometry immunophenotyping - A European LeukemiaNet WP10 study

Leukemia

Volumn 30, Issue 8, 2016, Pages 1769-1772

  Lacombe, F ^a   Bernal, E ^b   Bloxham, D ^c   Couzens, S ^d   Porta, M G D ^e   Johansson, U ^f   Kern, W ^g   Macey, M ^h   Matthes, T ⁱ   Morilla, R ^j   Paiva, A ^k   Palacio, C ^l   Preijers, F ^m   Ratei, R ⁿ   Siitonen, S ^o   Allou, K ^a   Porwit, A ^p   Bene M C ^q  

^a BORDEAUX UNIVERSITY HOSPITAL   (France)

^b DOUGLASS HANLY MOIR PATHOLOGY   (Australia)

^c ADDENBROOKE S HOSPITAL   (United Kingdom)

^d CARDIFF UNIVERSITY   (United Kingdom)

^e UNIVERSITY OF PAVIA   (Italy)

^f BRISTOL ROYAL INFIRMARY   (United Kingdom)

^g München Leukemia Labor   (Germany)

^h QUEEN MARY UNIVERSITY OF LONDON   (United Kingdom)

ⁱ GENEVA UNIVERSITY HOSPITALS   (Switzerland)

^j INSTITUTE OF CANCER RESEARCH   (United Kingdom)

^k CENTRO HOSPITALAR E UNIVERSITÁRIO DE COIMBRA   (Portugal)

^l HOSPITAL UNIVERSITARI VALL D HEBRON   (Spain)

^m RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

ⁿ HELIOS KLINIKUM BERLIN BUCH   (Germany)

^o HELSINKI UNIVERSITY CENTRAL HOSPITAL   (Finland)

^p UNIVERSITY OF TORONTO   (Canada)

^q NANTES UNIVERSITY HOSPITAL   (France)

more..

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBODY LABELING; COMPUTER PROGRAM; EUROPEAN; FLOW CYTOMETRY; HEMATOLOGIC MALIGNANCY; HUMAN; IMMUNOPHENOTYPING; LETTER; PRIORITY JOURNAL; STANDARDIZATION; DEVICES; EUROPE; HEMATOLOGIC DISEASE; STANDARDS;

EUROPE; FLOW CYTOMETRY; HEMATOLOGIC NEOPLASMS; HUMANS; IMMUNOPHENOTYPING;

EID: 84961226955     PISSN: 08876924     EISSN: 14765551     Source Type: Journal    
DOI: 10.1038/leu.2016.44     Document Type: Letter

References (9)

1. Swerdlow SH, Campo E, Harris NL, Jaffe ES, Pileri SA, Stein H, et al. WHO Classification of Tumours of Haematopoietic and Lymphoid Tissues, 4th edn. International Agency for Research on Cancer (IARC): Lyon, France, 2008
2. Béné MC, Nebe T, Bettelheim P, Buldini B, Bumbea H, Kern W, et al. Porwit immunophenotyping of acute leukemia and lymphoproliferative disorders: a consensus proposal of the European LeukemiaNet Work Package 10. Leukemia 2011; 25: 567-574
3. Craig FE, Foon KA. Flow cytometric immunophenotyping for hematologic neoplasms. Blood 2008; 111: 3941-3967
4. Béné MC, Castoldi G, Knapp W, Ludwig WD, Matutes E, Orfao, et al. Proposals for the immunological classification of acute leukemias. European Group for the Immunological Characterization of Leukemias (EGIL). Leukemia 1995; 9: 1783-1786
5. Kalina T, Flores-Montero J, van der Velden VH, Martin-Ayuso M, Böttcher S, Ritgen M, et al. EuroFlow standardization of flow cytometer instrument settings and immunophenotyping protocols. Leukemia 2012; 26: 1986-2010
6. Solly F, Rigollet L, Baseggio L, Guy J, Borgeot J, Guérin E, et al. Comparable flow cytometry data can be obtained with two types of instruments, Canto II, and Navios. A GEIL study. Cytometry A 2013; 83: 1066-1072
7. Preijers FW, Huys E, Favre C, Moshaver B. Establishment of harmonization in immunophenotyping: a comparative study of a standardized one-Tube lymphocyte-screening panel. Cytometry B Clin Cytom 2014; 86: 418-425
8. Mathis S, Chapuis N, Borgeot J, Maynadié M, Fontenay M, Béné MC, et al. Comparison of cross-platform flow cytometry minimal residual disease evaluation in multiple myeloma using a common antibody combination and analysis strategy. Cytometry B Clin Cytom 2015; 88: 101-109
9. GEIL National Meeting. Recommandations pour le process d'accréditation de la paillasse de cytométrie. Bordeaux, France, 2012